Access the full text.
Sign up today, get DeepDyve free for 14 days.
Daniel Lee, R. Gardner, D. Porter, C. Louis, N. Ahmed, M. Jensen, S. Grupp, C. Mackall (2014)
Current concepts in the diagnosis and management of cytokine release syndrome.Blood, 124 2
E. Wils, E. Rombouts, I. Mourik, H. Spits, N. Legrand, E. Braakman, J. Cornelissen (2011)
Stem Cell Factor Consistently Improves Thymopoiesis after Experimental Transplantation of Murine or Human Hematopoietic Stem Cells in Immunodeficient MiceThe Journal of Immunology, 187
P. Lan, N. Tonomura, A. Shimizu, Shumei Wang, Yong-Guang Yang (2006)
Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation.Blood, 108 2
T. Strowig, C. Gurer, A. Ploss, Yifang Liu, Frida Arrey, J. Sashihara, G. Koo, C. Rice, James Young, A. Chadburn, J. Cohen, C. Münz (2009)
Priming of protective T cell responses against virus-induced tumors in mice with human immune system componentsThe Journal of Experimental Medicine, 206
Grace Zheng, Jessica Terry, P. Belgrader, P. Ryvkin, Zachary Bent, Ryan Wilson, S. Ziraldo, T. Wheeler, Geoffrey McDermott, Junjie Zhu, M. Gregory, Joe Shuga, Luz Montesclaros, J. Underwood, D. Masquelier, S. Nishimura, Michael Schnall-Levin, Paul Wyatt, Christopher Hindson, R. Bharadwaj, Alexander Wong, K. Ness, Lan Beppu, H. Deeg, C. McFarland, K. Loeb, K. Loeb, W. Valente, W. Valente, Nolan Ericson, Emily Stevens, J. Radich, T. Mikkelsen, B. Hindson, J. Bielas (2016)
Massively parallel digital transcriptional profiling of single cellsNature Communications, 8
J. Kochenderfer, M. Dudley, S. Feldman, W. Wilson, D. Spaner, I. Maric, M. Stetler-Stevenson, G. Phan, M. Hughes, R. Sherry, J. Yang, U. Kammula, Laura Devillier, R. Carpenter, Debbie-Ann Nathan, R. Morgan, C. Laurencot, S. Rosenberg (2012)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells.Blood, 119 12
C. Turtle, K. Hay, L. Hanafi, Daniel Li, S. Cherian, Xueyan Chen, B. Wood, A. Lozanski, J. Byrd, S. Heimfeld, S. Riddell, D. Maloney (2017)
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35 26
C. Turtle, L. Hanafi, C. Berger, T. Gooley, S. Cherian, M. Hudecek, D. Sommermeyer, Katherine Melville, B. Pender, Tanya Budiarto, E. Robinson, Natalia Steevens, Colette Chaney, L. Soma, Xueyan Chen, C. Yeung, B. Wood, Daniel Li, Jianhong Cao, S. Heimfeld, M. Jensen, S. Riddell, D. Maloney (2016)
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.The Journal of clinical investigation, 126 6
Jae Park, I. Rivière, M. Gonen, Xiuyan Wang, B. Senechal, K. Curran, C. Sauter, Yongzeng Wang, B. Santomasso, E. Mead, M. Roshal, P. Maslak, M. Davila, R. Brentjens, M. Sadelain (2018)
Long‐Term Follow‐up of CD19 CAR Therapy in Acute Lymphoblastic LeukemiaThe New England Journal of Medicine, 378
D. Teachey, D. Teachey, S. Lacey, P. Shaw, J. Melenhorst, S. Maude, N. Frey, E. Pequignot, V. Gonzalez, Fang Chen, J. Finklestein, D. Barrett, S. Weiss, J. Fitzgerald, R. Berg, R. Aplenc, C. Callahan, S. Rheingold, Zhaohui Zheng, S. Rose-John, J. White, Farzana Nazimuddin, G. Wertheim, B. Levine, C. June, D. Porter, S. Grupp (2016)
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.Cancer discovery, 6 6
G. Bouma, T. Nikolić, J. Coppens, C. Helden-Meeuwsen, P. Leenen, H. Drexhage, S. Sozzani, M. Versnel (2005)
NOD mice have a severly impaired ability to recruit leukocytes into sites of inflammationEuropean Journal of Immunology, 35
Jacob Levine, Erin Simonds, S. Bendall, K. Davis, E. Amir, Michelle Tadmor, O. Litvin, Harris Fienberg, Astraea Jager, Eli Zunder, R. Finck, A. Gedman, I. Radtke, J. Downing, D. Pe’er, G. Nolan (2015)
Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with PrognosisCell, 162
S. Mastaglio, P. Genovese, Z. Magnani, E. Ruggiero, Elisa Landoni, B. Camisa, Giulia Schiroli, E. Provasi, A. Lombardo, A. Reik, Nicoletta Cieri, M. Rocchi, G. Oliveira, Giulia Escobar, M. Casucci, B. Gentner, A. Spinelli, A. Mondino, A. Bondanza, L. Vago, M. Ponzoni, F. Ciceri, M. Holmes, L. Naldini, C. Bonini (2017)
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease.Blood, 130 5
J. Kochenderfer, M. Dudley, Sadik Kassim, R. Somerville, R. Carpenter, M. Stetler-Stevenson, J. Yang, G. Phan, M. Hughes, R. Sherry, M. Raffeld, Steven Feldman, Lily Lu, Yong Li, L. Ngo, A. Goy, T. Feldman, D. Spaner, Michael Wang, Clara Chen, S. Kranick, A. Nath, Debbie-Ann Nathan, K. Morton, M. Toomey, S. Rosenberg (2015)
Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33 6
L. Gattinoni, D. Speiser, M. Lichterfeld, C. Bonini (2017)
T memory stem cells in health and diseaseNature Medicine, 23
E. Fox, N. Jayaprakash, Tuyet-Hang Pham, Ayana Rowley, C. McCully, F. Pucino, R. Goldbach-Mansky (2010)
The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primatesJournal of Neuroimmunology, 223
S. Maude, T. Laetsch, J. Buechner, S. Rives, M. Boyer, H. Bittencourt, P. Bader, M. Verneris, H. Stefanski, G. Myers, M. Qayed, B. Moerloose, H. Hiramatsu, Krysta Schlis, K. Davis, P. Martin, Eneida Nemecek, G. Yanik, C. Peters, A. Baruchel, N. Boissel, F. Mechinaud, A. Balduzzi, J. Krueger, C. June, B. Levine, P. Wood, T. Taran, M. Leung, K. Mueller, Yiyun Zhang, K. Sen, D. Lebwohl, M. Pulsipher, S. Grupp (2018)
Tisagenlecleucel in Children and Young Adults with B‐Cell Lymphoblastic LeukemiaThe New England Journal of Medicine, 378
A. Villani, R. Satija, G. Reynolds, Siranush Sarkizova, K. Shekhar, J. Fletcher, M. Griesbeck, Andrew Butler, Shiwei Zheng, S. Lazo, Laura Jardine, D. Dixon, Emily Stephenson, E. Nilsson, I. Grundberg, David McDonald, A. Filby, Weibo Li, P. Jager, O. Rozenblatt-Rosen, A. Lane, M. Haniffa, A. Regev, N. Hacohen (2017)
Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitorsScience, 356
S. Neelapu, F. Locke, N. Bartlett, L. Lekakis, D. Miklos, C. Jacobson, I. Braunschweig, O. Oluwole, T. Siddiqi, Yi Lin, J. Timmerman, P. Stiff, J. Friedberg, I. Flinn, A. Goy, B. Hill, Mitchell Smith, A. Deol, U. Farooq, P. Mcsweeney, J. Muñoz, I. Avivi, J. Castro, J. Westin, J. Chavez, A. Ghobadi, K. Komanduri, R. Levy, E. Jacobsen, T. Witzig, P. Reagan, A. Bot, J. Rossi, L. Navale, Yi-zhou Jiang, J. Aycock, M. Elias, David Chang, J. Wiezorek, W. Go (2017)
Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell LymphomaThe New England Journal of Medicine, 377
L. Shultz, P. Schweitzer, S. Christianson, B. Gott, I. Schweitzer, B. Tennent, McKenna Sd, L. Mobraaten, T. Rajan, D. Greiner (1995)
Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.Journal of immunology, 154 1
B. Savoldo, C. Ramos, E. Liu, M. Mims, M. Keating, G. Carrum, R. Kamble, C. Bollard, A. Gee, Z. Mei, Hao Liu, B. Grilley, C. Rooney, H. Heslop, M. Brenner, G. Dotti (2011)
CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients.The Journal of clinical investigation, 121 5
A. Bondanza, Veronica Valtolina, Z. Magnani, M. Ponzoni, K. Fleischhauer, M. Bonyhadi, C. Traversari, F. Sanvito, S. Toma, M. Radrizzani, S. Seta-Catamancio, F. Ciceri, C. Bordignon, C. Bonini (2005)
Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes.Blood, 107 5
K. Takenaka, Tatiana Prasolava, Jean Wang, Steven Mortin-Toth, S. Khalouei, O. Gan, J. Dick, J. Danska (2007)
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cellsNature Immunology, 8
C. Hunter, Simon Jones (2015)
IL-6 as a keystone cytokine in health and diseaseNature Immunology, 16
S. Grupp, M. Kalos, D. Barrett, R. Aplenc, David Porter, S. Rheingold, D. Teachey, A. Chew, B. Hauck, J. Wright, Michael Milone, Bruce Levine, Carl June (2013)
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.The New England journal of medicine, 368 16
A. Rongvaux, Hitoshi Takizawa, T. Strowig, T. Willinger, E. Eynon, R. Flavell, M. Manz (2013)
Human hemato-lymphoid system mice: current use and future potential for medicine.Annual review of immunology, 31
A. Bondanza, L. Hambach, Z. Aghai, B. Nijmeijer, S. Kaneko, S. Mastaglio, M. Radrizzani, K. Fleischhauer, F. Ciceri, C. Bordignon, C. Bonini, E. Goulmy (2011)
IL-7 receptor expression identifies suicide gene-modified allospecific CD8+ T cells capable of self-renewal and differentiation into antileukemia effectors.Blood, 117 24
J. Gust, K. Hay, K. Hay, L. Hanafi, Daniel Li, D. Myerson, D. Myerson, L. Gonzalez-Cuyar, Cecilia Yeung, C. Yeung, W. Liles, M. Wurfel, José López, Junmei Chen, D. Chung, Susanna Harju-Baker, Tahsin Özpolat, Kathleen Fink, S. Riddell, S. Riddell, D. Maloney, D. Maloney, C. Turtle, C. Turtle (2017)
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells.Cancer discovery, 7 12
M. Casucci, Benedetta Robilant, Laura Falcone, B. Camisa, M. Norelli, P. Genovese, B. Gentner, Fabiana Gullotta, M. Ponzoni, M. Bernardi, M. Marcatti, A. Saudemont, C. Bordignon, B. Savoldo, F. Ciceri, L. Naldini, G. Dotti, C. Bonini, A. Bondanza (2013)
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma.Blood, 122 20
D. Porter, B. Levine, M. Kalos, A. Bagg, C. June (2011)
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.The New England journal of medicine, 365 8
R. Goldbach-Mansky, Natalie Dailey, S. Canna, A. Gelabert, Janet Jones, B. Rubin, H. Kim, C. Brewer, C. Zalewski, E. Wiggs, S. Hill, M. Turner, B. Karp, I. Aksentijevich, F. Pucino, S. Penzak, M. Haverkamp, L. Stein, B. Adams, T. Moore, R. Fuhlbrigge, B. Shaham, J. Jarvis, K. O’neil, R. Vehe, L. Beitz, G. Gardner, W. Hannan, R. Warren, W. Horn, J. Cole, S. Paul, P. Hawkins, Tuyet-Hang Pham, Christopher Snyder, R. Wesley, S. Hoffmann, S. Holland, J. Butman, D. Kastner (2006)
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.The New England journal of medicine, 355 6
Nathan Singh, T. Hofmann, Zachary Gershenson, B. Levine, S. Grupp, D. Teachey, David Barrett (2017)
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function.Cytotherapy, 19 7
M. Davila, I. Rivière, Xiuyan Wang, S. Bartido, Jae Park, K. Curran, S. Chung, J. Stefanski, Oriana Bórquez-Ojeda, M. Olszewska, Jinrong Qu, Teresa Wasielewska, Q. He, Mitsú Fink, Himaly Shinglot, M. Youssif, M. Satter, Yongzeng Wang, James Hosey, Hilda Quintanilla, E. Halton, Y. Bernal, Diana Bouhassira, M. Arcila, M. Gonen, G. Roboz, P. Maslak, D. Douer, M. Frattini, S. Giralt, M. Sadelain, R. Brentjens (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaScience Translational Medicine, 6
R. Brentjens, I. Rivière, Jae Park, M. Davila, Xiuyan Wang, J. Stefanski, Clare Taylor, Raymond Yeh, S. Bartido, Oriana Bórquez-Ojeda, M. Olszewska, Y. Bernal, H. Pegram, M. Przybylowski, D. Hollyman, Y. Usachenko, Domenick Pirraglia, James Hosey, E. Santos, E. Halton, P. Maslak, D. Scheinberg, J. Jurcic, M. Heaney, G. Heller, M. Frattini, M. Sadelain (2011)
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias.Blood, 118 18
B. Nijmeijer, R. Willemze, J. Falkenburg (2002)
An animal model for human cellular immunotherapy: specific eradication of human acute lymphoblastic leukemia by cytotoxic T lymphocytes in NOD/scid mice.Blood, 100 2
E. Billerbeck, Walter Barry, Kathy Mu, M. Dorner, C. Rice, A. Ploss (2011)
Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rγ(null) humanized mice.Blood, 117 11
S. Kaneko, S. Mastaglio, A. Bondanza, M. Ponzoni, F. Sanvito, L. Aldrighetti, M. Radrizzani, S. Seta-Catamancio, E. Provasi, A. Mondino, T. Nagasawa, K. Fleischhauer, V. Russo, C. Traversari, F. Ciceri, C. Bordignon, C. Bonini (2009)
IL-7 and IL-15 allow the generation of suicide gene-modified alloreactive self-renewing central memory human T lymphocytes.Blood, 113 5
S. Schuster, J. Svoboda, E. Chong, S. Nasta, A. Mato, Ö. Anak, J. Brogdon, Iulian Pruteanu-Malinici, V. Bhoj, D. Landsburg, M. Wasik, B. Levine, S. Lacey, J. Melenhorst, D. Porter, C. June (2017)
Chimeric Antigen Receptor T Cells in Refractory B‐Cell LymphomasThe New England Journal of Medicine, 377
C. Turtle, L. Hanafi, C. Berger, M. Hudecek, B. Pender, E. Robinson, R. Hawkins, Colette Chaney, S. Cherian, Xueyan Chen, L. Soma, B. Wood, Daniel Li, S. Heimfeld, S. Riddell, D. Maloney (2016)
Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor–modified T cellsScience Translational Medicine, 8
M. Topp, N. Gökbuget, A. Stein, G. Zugmaier, S. O'brien, R. Bargou, H. Dombret, A. Fielding, L. Heffner, R. Larson, S. Neumann, R. Foà, M. Litzow, J. Ribera, A. Rambaldi, G. Schiller, M. Brüggemann, H. Horst, C. Holland, Catherine Jia, T. Maniar, B. Huber, D. Nagorsen, S. Forman, H. Kantarjian (2015)
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.The Lancet. Oncology, 16 1
S Mastaglio (2017)
NY-ESO-1 TCR single edited central memory and memory stem T cells to treat multiple myeloma without inducing GvHDBlood, 130
G. Koo, A. Hasan, R. O'reilly (2009)
Use of humanized severe combined immunodeficient mice for human vaccine developmentExpert Review of Vaccines, 8
Amit Patel, Yan Zhang, J. Fullerton, Lies Boelen, A. Rongvaux, Alexander Maini, V. Bigley, R. Flavell, D. Gilroy, Becca Asquith, D. Macallan, S. Yona (2017)
The fate and lifespan of human monocyte subsets in steady state and systemic inflammationThe Journal of Experimental Medicine, 214
In the clinic, chimeric antigen receptor–modified T (CAR T) cell therapy is frequently associated with life-threatening cytokine-release syndrome (CRS) and neurotoxicity. Understanding the nature of these pathologies and developing treatments for them are hampered by the lack of appropriate animal models. Herein, we describe a mouse model recapitulating key features of CRS and neurotoxicity. In humanized mice with high leukemia burden, CAR T cell–mediated clearance of cancer triggered high fever and elevated IL-6 levels, which are hallmarks of CRS. Human monocytes were the major source of IL-1 and IL-6 during CRS. Accordingly, the syndrome was prevented by monocyte depletion or by blocking IL-6 receptor with tocilizumab. Nonetheless, tocilizumab failed to protect mice from delayed lethal neurotoxicity, characterized by meningeal inflammation. Instead, the IL-1 receptor antagonist anakinra abolished both CRS and neurotoxicity, resulting in substantially extended leukemia-free survival. These findings offer a therapeutic strategy to tackle neurotoxicity and open new avenues to safer CAR T cell therapies.
Nature Medicine – Springer Journals
Published: May 28, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.